LONG-TERM OUTCOMES OF ANTI-VEGF THERAPY FOR MACULAR NEOVASCULARIZATION IN PRPH2-ASSOCIATED RETINOPATHY. Bianco L, Audo I, Antropoli A, Heath Jeffery RC, et al. Retina 2025 Apr 2. doi: 10.1097/IAE.0000000000004476.

Read + Share

Amedeo Smart

Independent Medical Education

Bianco L, Audo I, Antropoli A, Heath Jeffery RC, et al. LONG-TERM OUTCOMES OF ANTI-VEGF THERAPY FOR MACULAR NEOVASCULARIZATION IN PRPH2-ASSOCIATED RETINOPATHY. Retina 2025 Apr 2. doi: 10.1097/IAE.0000000000004476.
PMID: 40184549